1. Home
  2. AVDL vs CMRE Comparison

AVDL vs CMRE Comparison

Compare AVDL & CMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • CMRE
  • Stock Information
  • Founded
  • AVDL 2015
  • CMRE 1974
  • Country
  • AVDL Ireland
  • CMRE Monaco
  • Employees
  • AVDL N/A
  • CMRE N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • CMRE Marine Transportation
  • Sector
  • AVDL Health Care
  • CMRE Consumer Discretionary
  • Exchange
  • AVDL Nasdaq
  • CMRE Nasdaq
  • Market Cap
  • AVDL 1.5B
  • CMRE 1.3B
  • IPO Year
  • AVDL 1996
  • CMRE 2010
  • Fundamental
  • Price
  • AVDL $14.35
  • CMRE $11.53
  • Analyst Decision
  • AVDL Strong Buy
  • CMRE Hold
  • Analyst Count
  • AVDL 8
  • CMRE 1
  • Target Price
  • AVDL $20.88
  • CMRE $13.00
  • AVG Volume (30 Days)
  • AVDL 1.3M
  • CMRE 474.1K
  • Earning Date
  • AVDL 11-11-2025
  • CMRE 10-31-2025
  • Dividend Yield
  • AVDL N/A
  • CMRE 3.99%
  • EPS Growth
  • AVDL N/A
  • CMRE N/A
  • EPS
  • AVDL N/A
  • CMRE 2.37
  • Revenue
  • AVDL $221,075,000.00
  • CMRE $2,085,912,000.00
  • Revenue This Year
  • AVDL $64.56
  • CMRE N/A
  • Revenue Next Year
  • AVDL $30.60
  • CMRE N/A
  • P/E Ratio
  • AVDL N/A
  • CMRE $4.47
  • Revenue Growth
  • AVDL 132.35
  • CMRE 56.37
  • 52 Week Low
  • AVDL $6.38
  • CMRE $6.02
  • 52 Week High
  • AVDL $16.66
  • CMRE $13.16
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 43.90
  • CMRE 41.89
  • Support Level
  • AVDL $14.85
  • CMRE $11.75
  • Resistance Level
  • AVDL $15.58
  • CMRE $13.16
  • Average True Range (ATR)
  • AVDL 0.48
  • CMRE 0.35
  • MACD
  • AVDL -0.26
  • CMRE -0.17
  • Stochastic Oscillator
  • AVDL 12.16
  • CMRE 5.49

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

Share on Social Networks: